Matinas BioPharma Holdings (MTNB) Asset Utilization Ratio (2015 - 2023)

Matinas BioPharma Holdings (MTNB) has 9 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2023.

• Asset Utilization Ratio for Q4 2023 came in at 0.04, down 42.17% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.04 (down 42.17% YoY), and the FY2023 annual result was 0.03, down 47.81% from the prior year.
• Asset Utilization Ratio fell to 0.04 in Q4 2023 per MTNB's latest filing, from 0.07 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.09 in Q2 2023 and troughed at 0.0 in Q3 2021.
• A 5-year average of 0.03 and a median of 0.0 in 2020 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio tumbled 117.86% in 2021, then surged 13323.09% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2019, then tumbled by 78.56% to 0.0 in 2020, then increased by 13.61% to 0.0 in 2021, then jumped by 13323.09% to 0.07 in 2022, then tumbled by 42.17% to 0.04 in 2023.
• Business Quant data shows MTNB's Asset Utilization Ratio at 0.04 in Q4 2023, 0.07 in Q3 2023, and 0.09 in Q2 2023.